Citadel Advisors’s Stericycle Inc SRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-14,600
| Closed | -$891K | – | 15717 |
|
|
2024
Q3 | $891K | Sell |
14,600
-11,900
| -45% | -$706K | ﹤0.01% | 7102 |
|
|
2024
Q2 | $1.54M | Sell |
26,500
-13,500
| -34% | -$693K | ﹤0.01% | 5800 |
|
|
2024
Q1 | $2.11M | Sell |
40,000
-16,400
| -29% | -$825K | ﹤0.01% | 5416 |
|
|
2023
Q4 | $2.8M | Buy |
56,400
+54,600
| +3,033% | +$2.45M | ﹤0.01% | 4776 |
|
|
2023
Q3 | $80.5K | Sell |
1,800
-8,300
| -82% | -$371K | ﹤0.01% | 11171 |
|
|
2023
Q2 | $469K | Buy |
10,100
+6,200
| +159% | +$271K | ﹤0.01% | 8081 |
|
|
2023
Q1 | $170K | Buy |
3,900
+1,100
| +39% | +$54.4K | ﹤0.01% | 10440 |
|
|
2022
Q4 | $140K | Buy |
+2,800
| New | +$133K | ﹤0.01% | 10725 |
|
|
2022
Q2 | – | Sell |
-8,600
| Closed | -$507K | – | 14374 |
|
|
2022
Q1 | $507K | Sell |
8,600
-3,100
| -26% | -$180K | ﹤0.01% | 9362 |
|
|
2021
Q4 | $698K | Sell |
11,700
-9,300
| -44% | -$583K | ﹤0.01% | 8853 |
|
|
2021
Q3 | $1.43M | Sell |
21,000
-10,800
| -34% | -$746K | ﹤0.01% | 7216 |
|
|
2021
Q2 | $2.27M | Sell |
31,800
-42,800
| -57% | -$3.15M | ﹤0.01% | 6273 |
|
|
2021
Q1 | $5.04M | Buy |
74,600
+24,200
| +48% | +$1.64M | ﹤0.01% | 4243 |
|
|
2020
Q4 | $3.49M | Buy |
50,400
+7,200
| +17% | +$493K | ﹤0.01% | 4319 |
|
|
2020
Q3 | $2.72M | Buy |
43,200
+34,000
| +370% | +$2.09M | ﹤0.01% | 4148 |
|
|
2020
Q2 | $515K | Sell |
9,200
-9,100
| -50% | -$474K | ﹤0.01% | 7018 |
|
|
2020
Q1 | $889K | Buy |
18,300
+5,300
| +41% | +$312K | ﹤0.01% | 5542 |
|
|
2019
Q4 | $830K | Sell |
13,000
-25,200
| -66% | -$1.49M | ﹤0.01% | 5936 |
|
|
2019
Q3 | $1.95M | Sell |
38,200
-119,200
| -76% | -$5.55M | ﹤0.01% | 4521 |
|
|
2019
Q2 | $7.52M | Buy |
157,400
+116,900
| +289% | +$5.95M | ﹤0.01% | 2533 |
|
|
2019
Q1 | $2.2M | Buy |
40,500
+11,100
| +38% | +$502K | ﹤0.01% | 4300 |
|
|
2018
Q4 | $1.08M | Sell |
29,400
-12,200
| -29% | -$573K | ﹤0.01% | 5191 |
|
|
2018
Q3 | $2.44M | Buy |
41,600
+700
| +2% | +$44.7K | ﹤0.01% | 4063 |
|
|
2018
Q2 | $2.67M | Buy |
40,900
+1,000
| +3% | +$62.2K | ﹤0.01% | 3662 |
|
|
2018
Q1 | $2.33M | Buy |
39,900
+11,200
| +39% | +$758K | ﹤0.01% | 3494 |
|
|
2017
Q4 | $1.95M | Buy |
28,700
+2,300
| +9% | +$156K | ﹤0.01% | 3674 |
|
|
2017
Q3 | $1.89M | Sell |
26,400
-2,700
| -9% | -$199K | ﹤0.01% | 3473 |
|
|
2017
Q2 | $2.22M | Buy |
29,100
+4,900
| +20% | +$403K | ﹤0.01% | 3047 |
|
|
2017
Q1 | $2.01M | Sell |
24,200
-37,300
| -61% | -$3M | ﹤0.01% | 3078 |
|
|
2016
Q4 | $4.74M | Buy |
61,500
+21,800
| +55% | +$1.65M | ﹤0.01% | 2064 |
|
|
2016
Q3 | $3.18M | Buy |
39,700
+5,300
| +15% | +$479K | ﹤0.01% | 2441 |
|
|
2016
Q2 | $3.58M | Buy |
34,400
+10,500
| +44% | +$1.12M | ﹤0.01% | 2130 |
|
|
2016
Q1 | $3.02M | Buy |
23,900
+13,400
| +128% | +$1.56M | ﹤0.01% | 2240 |
|
|
2015
Q4 | $1.27M | Buy |
10,500
+2,400
| +30% | +$306K | ﹤0.01% | 3292 |
|
|
2015
Q3 | $1.13M | Sell |
8,100
-2,900
| -26% | -$404K | ﹤0.01% | 3651 |
|
|
2015
Q2 | $1.47M | Buy |
11,000
+4,000
| +57% | +$548K | ﹤0.01% | 3443 |
|
|
2015
Q1 | $983K | Buy |
7,000
+4,200
| +150% | +$567K | ﹤0.01% | 3943 |
|
|
2014
Q4 | $367K | Buy |
2,800
+900
| +47% | +$113K | ﹤0.01% | 5143 |
|
|
2014
Q3 | $221K | Sell |
1,900
-3,200
| -63% | -$378K | ﹤0.01% | 5628 |
|
|
2014
Q2 | $604K | Sell |
5,100
-5,000
| -50% | -$572K | ﹤0.01% | 4143 |
|
|
2014
Q1 | $1.15M | Sell |
10,100
-3,300
| -25% | -$382K | ﹤0.01% | 3261 |
|
|
2013
Q4 | $1.56M | Sell |
13,400
-9,000
| -40% | -$1.05M | ﹤0.01% | 2788 |
|
|
2013
Q3 | $2.58M | Buy |
22,400
+7,700
| +52% | +$888K | ﹤0.01% | 2165 |
|
|
2013
Q2 | $1.62M | Buy |
+14,700
| New | +$1.6M | ﹤0.01% | 2691 |
|
Other funds holding SRCL
KRSITF
AWM
IA
HNB
Citadel Advisors's SRCL Position: Q4 2024 in Review
Citadel Advisors sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 566,590 shares — an estimated $34.6M sold.
Citadel Advisors first reported a position in SRCL in Q2 2013 and held it in 41 quarters. The position peaked at $38.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.
- Citadel Advisors reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
- Citadel Advisors sold 566,590 Stericycle Inc shares in Q4 2024, an estimated $34.6M.
- Citadel Advisors first reported a position in Stericycle Inc in Q2 2013 and held it in 41 quarters.
- Citadel Advisors's Stericycle Inc position peaked at $38.4M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.